Sales and Marketing

Showing 15 posts of 11524 posts found.

Pepscan and Tibotec sign peptides deal

September 15, 2010 Research and Development, Sales and Marketing CLIPS, HIV, J&J, JJ, Pepscan, Tibotec

Pepscan Therapeutics, the biotech firm focusing on protein mimicry technology has signed a deal with Tibotec. Netherlands-based Pepscan will use …

Genzyme planning 1,000 job cuts

September 14, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, job cuts

Genzyme has said it intends to cut back its workforce by around 1,000 over the next 15 months in order …

NICE won’t approve Abilify without more data

September 13, 2010 Sales and Marketing Abilify, BMS, NICE

NICE is unlikely to approve Bristol-Myers Squibb’s schizophrenia drug Abilify unless the company can provide more data on its clinical …

Countdown to Launch

September 13, 2010 Sales and Marketing marketing, product launch

When NASA launches a rocket, most of the hard work is already done. The flight itself is relatively short, yet …
Patrick_Hopkinson

BMS appoints UK market access director

September 13, 2010 Sales and Marketing BMS, UK, appointment, sales and marketing

Patrick Hopkinson has joined Bristol-Myers Squibb as director of market access and external affairs in the UK. He joins the …
Novo Nordisk's Victoza

Low dose Victoza on track for NICE approval

September 10, 2010 Sales and Marketing NICE, Novo Nordisk, Victoza

Novo Nordisk is on track to receive NICE approval for its type II diabetes drug Victoza, but will still have …

J&J and Merck heading for showdown over drug rights

September 8, 2010 Sales and Marketing Johnson & Johnson, Merck, Remicade

Johnson & Johnson’s disagreement with Merck over rights to two arthritis drugs is set to come to a head in …

Pharma sector optimism growing

September 8, 2010 Sales and Marketing Eversheds, economic climate

Pharma execs are more confident about the sector’s outlook than they were at the start of the year. A survey …

Greece to cut 4,000 drug prices by a fifth

September 8, 2010 Sales and Marketing Greece, economic climate, price cuts, pricing & Reimbursement

The Greek government has released a list of over 4,000 drugs on which it will impose heavy price cuts. This …
Andreotti

BMS to acquire ZymoGenetics

September 8, 2010 Research and Development, Sales and Marketing BMS, hepatitis

 Bristol-Myers Squibb is to acquire biopharma company ZymoGenetics for $885 million to add to its ‘string of pearls’of small biotech …

New form of Levitra wins EU approval

September 7, 2010 Sales and Marketing Bayer, Levitra, erectile dysfunction

Bayer is to launch a new formulation of its erectile dysfunction drug Levitra. The European Commission granted Levitra (verdenafil HCI) …

Stephen Stamp joins board at Eusa Pharma

September 7, 2010 Sales and Marketing Eusa Pharma, appointment, sales and marketing

Transatlantic specialty company Eusa Pharma has appointed Stephen Stamp to its board as an independent non-executive director. Stephen has previously …

Pressure mounts on GSK over Avandia

September 6, 2010 Sales and Marketing Avandia, GlaxoSmithKline

GlaxoSmithKline is under mounting pressure this week as calls intensify for its type II diabetes drug Avandia to be withdrawn …

Parallel trading restricting medicine access, says ABPI

September 6, 2010 Sales and Marketing parallel trade, pharmacists, supply chain

The ABPI has blamed parallel trading by a minority of pharmacists as the root cause of the current medicines shortage …
The Gateway to Local Adoption Series

Latest content